Metabolic profiling of the synthetic cannabinoid APP-CHMINACA (PX-3) as studied by in vitro and in vivo models
Forensic Toxicology · 2025
DOI: 10.1007/s11419-024-00705-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Forensic Toxicology, 2025. Verfasst von Cristian Camuto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio Antidoping FMSI, Largo Giulio Onesti 1, 00197, Rome, Italy. Hauptthemen laut MEDLINE: Cannabinoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anti-Drug Policies Department, Presidency of the Council of Ministers, Italy, University of Lausanne.
Abstract (Originalsprache)
Purpose
The metabolic pathways of APP-CHMINACA were characterized to select the markers of intake for implementation into analytical assays used by the clinical and forensic communities. We have combined the evidences obtained by both in vitro experiments and administration studies on mice.
Methods
APP-CHMINACA was incubated with either human or mouse liver microsomes. Urine and blood samples were collected at different time points from mice after injection of a 3 mg/kg dose of the test compound. Samples were analyzed using liquid chromatography-tandem mass spectrometry.
Results
The in vitro studies allowed to isolate eight different metabolic reactions, formed by two metabolic routes, with no differences between human and mouse liver microsomes. The main biotransformation route involved the hydrolysis of the distal amide group and the subsequent hydroxylation on the cyclohexyl-methyl ring. The second route involved multiple hydroxylation of the parent compound, followed by reduction to generate minor metabolites. In blood samples, the most abundant substances identified were APP-CHMINACA unchanged and the metabolites formed by the hydrolysis of the distal amide together with its hydroxylated products. In urine samples, four metabolites formed following the hydroxylation of the distal amide hydrolysis metabolite were detected as the most abundant and long-term metabolites.
Conclusions
The outcomes of our study showed that the most suitable markers to detect the intake of APP-CHMINACA in blood and urine samples in the framework of toxicological, clinical and forensic investigations were the metabolite formed by the hydrolysis of the distal amide and its hydroxylated products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio Antidoping FMSI, Largo Giulio Onesti 1, 00197, Rome, Italy.
- Department of Health Care Surveillance and Bioethics, Section of Legal Medicine, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, Rome, Italy.
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, Rome, Italy.
- Department of Translational Medicine, University of Ferrara, Via Fossato Di Mortara 70, Ferrara, Italy.
- DoCoLab, University of Ghent, Block B, Ottergemsesteenweg 460, 9000, Ghent, Belgium.
- Department of Anti-Drug Policies, Collaborative Center for the Italian National Early Warning System, Presidency of the Council of Ministers, Rome, Italy.
ORCID-Profile: Francesco Botrè
Förderung
- Anti-Drug Policies Department, Presidency of the Council of Ministers, Italy
- University of Lausanne
Zitieren
APA
Camuto, C., De-Giorgio, F., Corli, G., Bilel, S., Mazzarino, M., Marti, M., & Botrè, F. (2025). Metabolic profiling of the synthetic cannabinoid APP-CHMINACA (PX-3) as studied by in vitro and in vivo models. Forensic Toxicology. https://doi.org/10.1007/s11419-024-00705-0
Vancouver
Camuto C, De-Giorgio F, Corli G, Bilel S, Mazzarino M, Marti M, et al. Metabolic profiling of the synthetic cannabinoid APP-CHMINACA (PX-3) as studied by in vitro and in vivo models. Forensic Toxicology. 2025. doi:10.1007/s11419-024-00705-0
BibTeX
@article{Camuto2025,
author = {Camuto, Cristian and De-Giorgio, Fabio and Corli, Giorgia and Bilel, Sabrine and Mazzarino, Monica and Marti, Matteo and Botrè, Francesco},
title = {Metabolic profiling of the synthetic cannabinoid APP-CHMINACA (PX-3) as studied by in vitro and in vivo models},
journal = {Forensic Toxicology},
year = {2025},
doi = {10.1007/s11419-024-00705-0}
}
EUVIMED